Skip to content
Dose Brief
Menu

Provider review

Verge review

By · Updated

Verge distinguishes subscription and one-time purchases, but its 25-day and 80-day renewals make the monthly labels easy to misread.

Not rated. This review examines published program information; it is not a firsthand treatment review.

At a glance

Semaglutide
$175 one-time one-month order; $170 subscription renews every 25 days; $390 three-month subscription renews every 80 days
Tirzepatide
$275 one-time one-month order; $270 subscription renews every 25 days; $705 three-month subscription renews every 80 days
Availability
Advertises all 50 states with treatment-specific eligibility restrictions; confirm your prescribed product.
Treatment formats
Compounded semaglutide and tirzepatide weekly injections.

Subscription charges recur every 25 or 80 days, not calendar months or quarters. Selected supply is paid upfront.

In this review

The renewal interval changes the price comparison

Verge’s semaglutide subscription is $170 every 25 days, or $390 upfront for a three-month supply with renewal every 80 days. Tirzepatide uses the same schedules at $270 and $705. These are not calendar-month or calendar-quarter charges. Budget from the actual renewal dates rather than multiplying a monthly headline by twelve; our billing-cycle comparison explains why shorter cycles change annual spending.

One-time orders cost more per purchase

Separate non-subscription options list semaglutide at $175 for one month or $450 for three, and tirzepatide at $275 or $720. Those purchases avoid automatic renewal, but they do not create an unrestricted right to cancel a processed prescription. The treatment page advertises unchanged pricing across doses, included supplies and expedited shipping. Confirm quantity and dispensing instructions for the actual prescription.

Subscription labels and disclaimers conflict

The weight-loss page clearly labels subscription plans and renewal intervals, while its product disclaimer also says the product has no subscriptions or automatic renewals. The detailed subscription terms repeat the 25-day and 80-day schedules. Before paying, make sure your order confirmation explicitly identifies a one-time purchase or recurring plan rather than relying on the general disclaimer.

Who provides the care?

The terms identify Verge Health Group LLC as the platform operator and Telegra MD, LLC as the independent clinical group with affiliated professional entities. The reviewed pages do not establish the dispensing pharmacy for an individual order. The FAQ advertises nationwide service while noting that treatment options vary by state. A clinician-network claim does not guarantee eligibility for either compound.

Payment and cancellation need separate answers

One terms section says the full purchase is charged when ordered. A later payment section describes a temporary authorization followed by capture after consultation and approval, with release in five to seven business days if treatment is declined. The same terms generally restrict refunds after approval or pharmacy transmission and allow a discretionary cancellation fee up to $50 after review begins. Get the applicable charge timing and refund rule in writing.

The practical trade-off

Subscription cancellation is described as free when completed before renewal, but that does not erase an already initiated medication order or its costs. Verge can suit readers who want a clearly priced one-time supply option; the subscription comparison requires more care because renewals arrive sooner than the plan names suggest. Resolve conflicting payment language and identify the pharmacy before committing.

What stands out

  • Separately prices subscriptions and one-time orders
  • States precise renewal intervals
  • Names the independent clinical group

What to check

  • Monthly labels obscure 25-day billing
  • Subscription disclaimer conflicts with plan table
  • Payment-capture clauses disagree
  • Assigned pharmacy remains unconfirmed

Sources and review scope

Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.